Mostrar el registro sencillo del ítem
| dc.contributor.author | Morella-Fernández, Marta | |
| dc.contributor.author | Balsalobre-Yago, José | |
| dc.contributor.author | Martínez-García, J | |
| dc.contributor.author | Peláez-Gutiérrez, Mercedes | |
| dc.contributor.author | López-Muñoz, A | |
| dc.contributor.author | Silvestre-Ballesta, Ana-Isabel | |
| dc.contributor.author | Sánchez-Lafuente, B | |
| dc.contributor.author | Martínez-Martín, I | |
| dc.contributor.author | Cerezuela-Fuentes, Pablo | |
| dc.date.accessioned | 2026-03-10T11:56:13Z | |
| dc.date.available | 2026-03-10T11:56:13Z | |
| dc.date.issued | 2025-03 | |
| dc.identifier.citation | Morellá Fernández M, Balsalobre Yago J, Martínez García J, Peláez Gutiérrez M, López Muñoz A, Silvestre Ballesta AI, et al. [Translated article] Real-World Evidence of Adjuvant Immunotherapy in Resected Stage III and IV Melanoma Patients: CADIM Trial Final Results. Experience From 2 Tertiary Referral Centers. Actas Dermo-Sifiliográficas. marzo de 2025;116(3):T218-24. doi:10.1016/j.ad.2024.12.008 | |
| dc.identifier.issn | 0001-7310 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/25388 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER ESPAÑA | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
| dc.title | Real-World Evidence of Adjuvant Immunotherapy in Resected Stage III and IV Melanoma Patients: CADIM Trial Final Results. Experience From 2 Tertiary Referral Centers | |
| dc.type | info:eu-repo/semantics/article | |
| dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S0001731024009979 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1016/j.ad.2024.12.008 | |
| dc.journal.title | Actas Dermo-Sifiliograficas | |
| dc.identifier.essn | 1578-2190 |